|
因子II和X浓缩物[第4批国际标准]11/126
|
EA
|
11/126
|
4988
|
1-4/12周
|
|
流感病毒传染性NYMCX-18711/108
|
EA
|
11/108
|
咨询
|
1-4/12周
|
|
SARS-CoV-2XBB.2.3分离株101121
|
EA
|
101121
|
1717
|
1-4/12周
|
|
抗SARS-CoV-2RBDOmicron变体特异性单克隆抗体,克隆304101118-B
|
EA
|
101118-B
|
咨询
|
1-4/12周
|
|
抗SARS-CoV-2RBD交叉反应单克隆抗体,克隆175101119-A
|
EA
|
101119-A
|
1717
|
1-4/12周
|
|
抗SARS-CoV-2RBD交叉反应单克隆抗体,克隆175101119-B
|
EA
|
101119-B
|
咨询
|
1-4/12周
|
|
SARS-CoV-2XBB.1.16分离株101120
|
EA
|
101120
|
1717
|
1-4/12周
|
|
SARS-CoV-2EG.5.1.1分离株101122
|
EA
|
101122
|
1717
|
1-4/12周
|
|
SARS-CoV-2Omicron-BQ.1.14谱系101112
|
EA
|
101112
|
咨询
|
1-4/12周
|
|
抗SARS-CoV-2RBD武汉变种特异性单克隆抗体,克隆486101116-A
|
EA
|
101116-A
|
1717
|
1-4/12周
|
|
抗SARS-CoV-2RBD武汉变种特异性单克隆抗体,克隆486101116-B
|
EA
|
101116-B
|
咨询
|
1-4/12周
|
|
抗SARS-CoV-2RBDOmicron变体特异性单克隆抗体,克隆304101118-A
|
EA
|
101118-A
|
1717
|
1-4/12周
|
|
抗SARS-CoV-2RBDDelta变体特异性单克隆抗体,克隆215101117-A
|
EA
|
101117-A
|
1717
|
1-4/12周
|
|
抗SARS-CoV-2RBDDelta变体特异性单克隆抗体,克隆215101117-B
|
EA
|
101117-B
|
咨询
|
1-4/12周
|
|
SARS-CoV-2Deltacron-重组XD谱系101109
|
EA
|
101109
|
咨询
|
1-4/12周
|
|
SARS-CoV-2Omicron-重组XZ谱系101107
|
EA
|
101107
|
1717
|
1-4/12周
|
|
SARS-CoV-2Omicron-BA.2.9.3谱系101106
|
EA
|
101106
|
1717
|
1-4/12周
|
|
SARS-CoV-2Omicron-BQ.1谱系101111
|
EA
|
101111
|
咨询
|
1-4/12周
|
|
SARS-CoV-2Omicron-重组XN谱系101110
|
EA
|
101110
|
咨询
|
1-4/12周
|
|
SARS-CoV-2Omicron-BA.2谱系101105
|
EA
|
101105
|
1717
|
1-4/12周
|